1. The cancer registry as a cancer-control tool.

    Cancer 122(9):1343 (2016) PMID 26959554

  2. Some thoughts on health surveillance data, race, and population categorization.

    CA: A Cancer Journal for Clinicians 66(3):179 (2016) PMID 26998579

    PDF not found
  3. Cancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screening.

    CA: A Cancer Journal for Clinicians 66(2):96 (2016) PMID 26797525

    Each year the American Cancer Society (ACS) publishes a summary of its guidelines for early cancer detection, data and trends in cancer screening rates, and select issues related to cancer screening. In this issue of the journal, we summarize current ACS cancer screening guidelines, including th...
    PDF not found
  4. Evolving Recommendations on Prostate Cancer Screening.

    ASCO Educational Book 35:e80 (2016) PMID 27249774

    Results of a number of studies demonstrate that the serum prostate-specific antigen (PSA) in and of itself is an inadequate screening test. Today, one of the most pressing questions in prostate cancer medicine is how can screening be honed to identify those who have life-threatening disease and ...
  5. The Meaning of Race in Prostate Cancer Treatment.

    JAMA Oncology 2(1):93 (2016) PMID 26502032

  6. How many individuals will need to be screened to increase colorectal cancer screening prevalence to 80% by 2018?

    Cancer 121(23):4258 (2015) PMID 26308967

    A recent study estimates that 277,000 colorectal cancer (CRC) cases and 203,000 CRC deaths will be averted between 2013 and 2030 if the National Colorectal Cancer Roundtable goal of increasing CRC screening prevalence to 80% by 2018 is reached. However, the number of individuals who need to be s...
  7. Reviewer acknowledgment 2015.

    CA: A Cancer Journal for Clinicians 65(6):511 (2015) PMID 26271076

    PDF not found
  8. Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society.

    JAMA 314(15):1599 (2015) PMID 26501536 PMCID PMC4831582

    Breast cancer is a leading cause of premature mortality among US women. Early detection has been shown to be associated with reduced breast cancer morbidity and mortality. To update the American Cancer Society (ACS) 2003 breast cancer screening guideline for women at average risk for breast canc...
  9. Editorial Comment.

    Urology 86(3):504 (2015) PMID 26282018

  10. Advancing a Quality-of-Life Agenda in Cancer Advocacy: Beyond the War Metaphor.

    JAMA Oncology 1(4):423 (2015) PMID 26181244

  11. Ovarian cancer prevention: Time for primetime?

    Cancer 121(13):2121 (2015) PMID 25820436

  12. CDC Grand Rounds: the future of cancer screening.

    Morbidity and Mortality Weekly Report 64(12):324 (2015) PMID 25837243

    Cancer is the second leading cause of death in the United States, with 52% of deaths caused by cancers of the lung and bronchus, female breast, uterine cervix, colon and rectum, oral cavity and pharynx, prostate, and skin (melanoma). In the 1930s, uterine cancer, including cancer of the uterine ...
  13. Cancer statistics: Breast cancer in situ.

    CA: A Cancer Journal for Clinicians 65(6):481 (2015) PMID 26431342

    An estimated 60,290 new cases of breast carcinoma in situ are expected to be diagnosed in 2015, and approximately 1 in 33 women is likely to receive an in situ breast cancer diagnosis in her lifetime. Although in situ breast cancers are relatively common, their clinical significance and optimal ...
    PDF not found
  14. Cancer screening in the United States, 2015: a review of current American cancer society guidelines and current issues in cancer screening.

    CA: A Cancer Journal for Clinicians 65(1):30 (2015) PMID 25581023

    Each year, the American Cancer Society (ACS) publishes a summary of its guidelines for early cancer detection along with a report on data and trends in cancer screening rates and select issues related to cancer screening. In this issue of the journal, we summarize current ACS cancer screening gu...
    PDF not found
  15. Reviewer acknowledgment 2014.

    CA: A Cancer Journal for Clinicians 64(6):446 (2014) PMID 25382160

    PDF not found
  16. Prevention and early detection of prostate cancer.

    The Lancet Oncology 15(11):e484 (2014) PMID 25281467 PMCID PMC4203149

    Prostate cancer is a common malignancy in men and the worldwide burden of this disease is rising. Lifestyle modifications such as smoking cessation, exercise, and weight control offer opportunities to reduce the risk of developing prostate cancer. Early detection of prostate cancer by prostate-s...
  17. Breast cancer screening: time for rational discourse.

    Cancer 120(18):2800 (2014) PMID 24925095

  18. The National Breast and Cervical Cancer Early Detection Program: toward a system of cancer screening in the United States.

    Cancer 120 Suppl 16:2617 (2014) PMID 25099906

    In the mid-1980s when there was a shift in public health priorities toward the prevention and control of chronic disease, the Centers for Disease Control and Prevention (CDC) developed a screening program based on the core elements of surveillance, public and provider education, quality assuranc...
  19. The argument for breast cancer screening.

    Clinical advances in hematology & oncology : H&O 12(6):407, 410 (2014) PMID 25134178

  20. Low-dose spiral CT screening and evaluation of the solitary pulmonary nodule.

    Oncology (Williston Park, N.Y.) 28(5):441 (2014) PMID 25004661

    Lung cancer screening using helical low-dose computerized tomography (LDCT) increased drastically after publication of a successful well-designed prospective randomized screening study, the National Lung Screening Trial. This increase in screening has led to a significant increase in the diagnos...